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Abstract
Organisms are constantly challenged by stresses and privations and require adaptive responses for
their survival. The transcription factor DAF-16/FOXO is central nexus in these responses, but
despite its importance little is known about how it regulates its target genes. Proteomic
identification of DAF-16/FOXO binding partners in Caenorhabditis elegans and their subsequent
functional evaluation by RNA interference (RNAi) revealed several candidate DAF-16/FOXO
cofactors, most notably the chromatin remodeller SWI/SNF. DAF-16/FOXO and SWI/SNF form a
complex and globally colocalize at DAF-16/FOXO target promoters. We show that specifically
for gene-activation, DAF-16/FOXO depends on SWI/SNF, facilitating SWI/SNF recruitment to
target promoters, in order to activate transcription by presumed remodelling of local chromatin.
For the animal, this translates into an essential role of SWI/SNF for DAF-16/FOXO-mediated
processes, i.e. dauer formation, stress resistance, and the promotion of longevity. Thus we give
insight into the mechanisms of DAF-16/FOXO-mediated transcriptional regulation and establish a
critical link between ATP-dependent chromatin remodelling and lifespan regulation.
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The ability to adapt to stresses and privations is crucial for the survival and thus the
longevity of any species. Sophisticated mechanisms are in place to perceive such dire
conditions and relay them into the appropriate responses, i.e. cytoprotective and homeostatic
measures and sometimes even a reversible cessation of development or reproduction1. A
core pathway for these responses in animals is the environmentally responsive insulin-like
signalling pathway with its conserved downstream component, the forkhead transcription
factor DAF-16/FOXO2. In the presence of ample food and optimal conditions, high insulin-
like signalling inactivates DAF-16/FOXO via AKT kinase-mediated phosphorylation,
causing cytoplasmic sequestration of DAF-16/FOXO by 14-3-3 proteins. Conversely, upon
dire conditions, i.e. cues that reduce insulin-like signalling and thus allow for reversal of
DAF-16/FOXO phosphorylation, sequestration is alleviated, enabling DAF-16/FOXO to
translocate to the nucleus, where it engages in transcriptional regulation. Several hundred
DAF-16/FOXO target genes have been identified, and it is their concerted action that
confers a wide range of beneficial effects upon the organism – most notably stress resistance
and longevity, but also metabolic responses, stem cell maintenance, and tumour
suppression3,4. Although many studies have explored the signalling pathways leading to
DAF-16/FOXO activation, little is known about the mechanisms or cofactors by which
DAF-16/FOXO regulates its target genes.
Results
Identification of candidate DAF-16/FOXO cofactors
To address this problem we used the nematode Caenorhabditis elegans, a model system that
has been instrumental in dissecting the functions of DAF-16/FOXO, mostly due to its
amenability for genetic manipulation and its compatibility with high-throughput screening
approaches for developmental arrest, stress resistance and lifespan phenotypes. We
biochemically characterized DAF-16/FOXO by size exclusion chromatography of whole C.
elegans lysates, which revealed that a significant amount of DAF-16/FOXO partitions to
high molecular weight fractions (Fig. 1a). Activation of DAF-16/FOXO in a daf-2/insulin-
like growth factor mutant background increased the partitioning of DAF-16/FOXO to these
fractions (Fig. 1a), suggesting that DAF-16/FOXO activity involves and maybe even
requires binding to other proteins, i.e. cofactors. Hence we conducted a screen to identify
cofactors of DAF-16/FOXO, in which we combined proteomic identification of DAF-16/
FOXO binding partners with high-throughput functional assays using RNA interference
(RNAi) (Fig. 1b). Epitope-tagged DAF-16/FOXO was immunoprecipitated in different
states of activation, using three different C. elegans genetic backgrounds: wild-type
(DAF-16 partially active), daf-2(e1370ts) at restrictive temperature (insulin/IGF receptor
mutant; DAF-16 fully active), or daf-18(mg198lf) (PTEN mutant, causing constitutively
high PIP3 signalling which in turn constitutively activates the AKT kinases that
phosphorylate and inactivate DAF-16/FOXO; DAF-16 inactive). Proteins that specifically
co-purified with DAF-16/FOXO were identified by tandem mass spectrometry (LC-MS/MS;
see also Fig. 1c). In addition to previously known DAF-16/FOXO binding partners (i.e. the
14-3-3 proteins FTT-2 and PAR-55), we identified 131 new binding partners of DAF-16/
FOXO, the majority of which were enriched in purifications of active DAF-16/FOXO
(Table S1).
To identify potential DAF-16/FOXO cofactors amongst these binding partners, we silenced
their expression by RNAi and examined a range of aging and gene expression phenotypes
expected from altered DAF-16/FOXO activity: To identify cofactors required for DAF-16/
FOXO activity, we tested each gene inactivation for impaired DAF-16/FOXO-induced
lifespan extension or an inability to up-regulate the DAF-16/FOXO-activated gene sod-3 in
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daf-2 mutant animals (Tables 1, S2, S3). To identify interacting proteins that antagonize
DAF-16/FOXO activity, we tested each gene inactivation for an extension of lifespan or
inappropriate induction of sod-3 in otherwise wild-type animals (Tables S4–S6). Out of 72
DAF-16/FOXO binding partners tested, inactivation of the genes encoding 32 of them
caused significant phenotypes in at least one of the assays. Thus they were considered
candidate cofactors of DAF-16/FOXO (Tables 1, S6). Comparison of the frequency of
phenotypes in Table S2 with a similar genome-wide survey6 indicated that our list of
binding partners was more than 20-fold enriched for proteins involved in DAF-16/FOXO
function, underscoring the utility of this co-purification approach. Many of the 32 candidate
cofactors act in the regulation of chromatin and transcription (e.g. SWSN-1, SWSN-3,
BAF-1, ELB-1, DCP-66, DPY-30, ZFP-1, MRG-1) or protein folding/homeostasis (e.g.
RPN-9, RPN-12, CCT-8, PFD-6, PFD-2) (Tables 1, S6), both of which are important for
stress response and lifespan regulation7,8. And some of the candidate cofactors even
emerged from previous aging-related studies, e.g. BAF-1 controls age-dependent muscle
integrity9 and CCT-8 is a component of the lifespan-regulatory cytosolic chaperonin T
complex10.
SWI/SNF binds to and colocalizes with DAF-16/FOXO
While follow-up of several of these candidate cofactors may yield compelling insight into
DAF-16/FOXO mechanism and function, we focused on a candidate with particularly strong
phenotypes in both, regulation of lifespan and expression of sod-3: SWSN-1 (ortholog of
human BAF155/170), a core subunit of the chromatin remodeller SWI/SNF. Two additional
SWI/SNF subunits, SWSN-3 (ortholog of human BAF57) and SWSN-8 (ortholog of human
OSA/BAF250), were amongst our 32 candidate cofactors or at least emerged from the
proteomic analysis (Tables 1, S1).
SWI/SNF is an essential 1–2 MDa multi-subunit complex that repositions, exchanges, or
displaces nucleosomes in an ATP-dependent manner11,12 (Fig. S1a,b). The BRG1/BRM
ortholog SWSN-4 provides the complex’s catalytic activity and comprises, together with
SWSN-1/BAF155/170 and SNFC-5/INI1, its core subunits13. Additional accessory subunits
direct the specificity of the complex. In particular two subclasses of SWI/SNF, BAF and
PBAF, which differ by the presence of accessory signature subunits (i.e. SWSN-8/OSA and
PBRM-1/Polybromo (Fig. S1a,b)), show distinct functions14,15. Although chromatin
remodelling is a ubiquitous process, the roles of SWI/SNF are surprisingly confined. For
example, in yeast only 6% of all gene expression events depend on SWI/SNF16, suggesting
that particular mechanisms direct SWI/SNF to specific sites.
In C. elegans, studies on SWI/SNF have remained few – mostly focused on its role in
asymmetric T-cell division and gonad morphogenesis15,17. To explore the relationship
between DAF-16/FOXO and SWI/SNF, we first confirmed the interaction between DAF-16/
FOXO and SWI/SNF subunits (including its catalytic core SWSN-4/BRG1) and excluded
the possibility of a DNA-mediated interaction by co-immunoprecipitation (co-IP) in the
presence of Benzonase, a nuclease that degrades DNA and RNA (Fig. 1d,e). Next we
determined in which tissues and subcellular compartments DAF-16/FOXO and SWI/SNF
are coexpressed and hence their interaction may occur. Both were expressed globally,
including the tissues important for DAF-16/FOXO function (i.e. intestine and neurons)17,18
(Fig. S1c). While inactive DAF-16/FOXO (e.g. in daf-18(mg198lf)) is sequestered in the
cytoplasm and only translocates to the nucleus upon its activation (e.g. in daf-2(e1370ts)),
SWI/SNF subunits resided constitutively in the nucleus15,17,19 (Fig. S1c, data not shown).
Consistent with this observation, mass spectrometric comparison of the DAF-16/FOXO
purifications from wild-type, daf-2(e1370ts), and daf-18(mg198lf) animals revealed a
positive correlation between the activation of DAF-16/FOXO and its binding to SWI/SNF
(comparison based on spectral counts, Table S1). Thus it appears that DAF-16/FOXO and
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SWI/SNF encounter each other in most cell types, with their interaction preferentially
occurring upon DAF-16/FOXO activation and translocation into the nucleus, i.e. under low
insulin-like signalling conditions.
SWI/SNF is required for DAF-16/FOXO-mediated transcriptional regulation
Next we evaluated the importance of SWI/SNF for DAF-16/FOXO activity. Since DAF-16/
FOXO exerts its function by transcriptional regulation of target genes, we tested whether
SWI/SNF is required for this regulation to occur. We used transcriptional reporters of two
DAF-16/FOXO-regulated genes, sod-3 and ins-7, to examine DAF-16/FOXO-dependent
transcriptional activation and repression, respectively6,20. Expression of the Psod-3::GFP
reporter is induced under conditions of low insulin-like signalling, e.g. in daf-2 mutants18.
Additional inactivation by RNAi of DAF-16/FOXO or of the SWI/SNF core subunits
SWSN-4/BRG1, SWSN-1/BAF155/170 and the BAF-subclass signature subunit SWSN-8/
OSA, suppressed this induction of Psod-3::GFP (Fig. 2a,b). Likewise, repression of
Pins-7::ins-7::GFP was suppressed by RNAi against SWI/SNF subunits, in particular
SWSN-4/BRG1 and SWSN-1/BAF155/170 and to a lesser extent SWSN-8/OSA, SWSN-3/
BAF57, and SNFC-5/INI1 (Fig. 2c,d). It is important to note that in contrast to the BAF-
subclass signature subunit SWSN-8/OSA, RNAi against the PBAF-subclass signature
subunits PBRM-1/Polybromo, TAG-298/BRD7, or SWSN-7/BAF200 (by validated RNAi
conditions (Fig. S2)) yielded no significant phenotypes in these assays, suggesting that
specifically a BAF-like subclass of the SWI/SNF complex mediates DAF-16/FOXO
functions.
We then tested whether SWI/SNF is required for the regulation of endogenous DAF-16/
FOXO target genes genome-wide. By high-throughput sequencing of mRNA (mRNA-Seq),
we compared gene expression levels between wild-type, daf-2(e1370ts), daf-2(e1370ts);
daf-16(0), and daf-2(e1370ts); swsn-1(os22ts) young adult animals at restrictive
temperature. First we tested whether daf-16(0) or swsn-1(os22ts) could suppress the
differential gene expression caused by decreased insulin-like signalling in daf-2(e1370ts),
which is thought to be entirely mediated by DAF-16/FOXO3. As indicated by an extensive
reversal of the differential gene expression to wild-type levels (78% of genes activated and
71% of genes repressed in the daf-2(e1370ts) mutant), daf-16(0) largely suppressed the gene
expression changes induced by daf-2(e1370ts) (Fig. 3a,b). Likewise swsn-1(os22ts)
significantly reversed this differential gene expression, although to a lesser extent (42% of
genes activated and 32% of genes repressed in the daf-2(e1370ts) mutant were reverted; Fig.
3a,b). This could be due to swsn-1(os22ts) being a non-null and therefore weaker allele than
daf-16(0), SWSN-1 being less important, or it acting on only a subset of DAF-16/FOXO
target genes. Next we determined the overlap between DAF-16/FOXO- and SWI/SNF-
regulated genes. Importantly, although DAF-16/FOXO and SWI/SNF each regulate only a
small fraction of the genome (5.9% and 7.5%, respectively), their dependent gene sets
showed substantial and significant overlap: Of the 656 genes activated and 356 genes
repressed by DAF-16/FOXO in daf-2(e1370ts) animals, 32% (211) of the activated and 15%
(53) of the repressed genes were co-regulated by SWI/SNF (Fig. 3c), suggesting that a large
fraction of DAF-16/FOXO-mediated gene regulatory events require SWI/SNF. GO-term
analysis of the co-dependent genes showed significant enrichment for genes involved in
aging, oxidative stress response, and organismal defence (Table S7). Focusing on DAF-16/
FOXO target genes, specifically for genes activated by DAF-16/FOXO we observed a
strong positive correlation between the extent of DAF-16/FOXO-mediated activation and
the requirement of SWI/SNF for this activation to occur (as indicated by a declining
trendline in Figure 3d, right panel). No such substantial correlation was found for genes non-
regulated or repressed by DAF-16/FOXO (Fig. 3d, left and middle panels). Thus SWI/SNF
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is required for the regulation of a large subset of DAF-16/FOXO target genes –
predominantly those activated by DAF-16/FOXO.
DAF-16/FOXO and SWI/SNF colocalize on chromatin
We then sought the mechanism by which SWI/SNF impacts DAF-16/FOXO-mediated gene
regulation. Given that SWI/SNF and activated DAF-16/FOXO are both known to associate
with DNA2,11,12, we determined the genome-wide positioning of DAF-16/FOXO, the SWI/
SNF catalytic subunit SWSN-4/BRG1, and the SWI/SNF core regulatory subunit SWSN-1/
BAF155/170 in daf-2(e1370ts) animals at restrictive temperature using chromatin
immunoprecipitation followed by high-throughput sequencing (ChIP-Seq). Using strains
expressing either DAF-16::GFP, SWSN-4::GFP, or SWSN-1::GFP, we identified 1952
binding sites for DAF-16/FOXO, 3804 binding sites for SWSN-4/BRG1, and 5727 binding
sites for SWSN-1/BAF155/170. Despite our use of multi-copy transgenes that may express
at non-physiological levels, we observed a reassuring enrichment for the canonical DAF-16/
FOXO associated motif TRTTTAC3 at DAF-16/FOXO binding sites. SWSN-4/BRG1 and
SWSN-1/BAF155/170 binding sites were likewise enriched for several motifs, although
motifs of less defined roles (Table S8). Interestingly, not only SWI/SNF but also DAF-16/
FOXO binding sites shared enrichment for a motif known to associate with Trithorax-like, a
protein of Drosophila melanogaster that is functionally related to SWI/SNF21 (Table S8).
DAF-16/FOXO binding sites in daf-2(e1370ts) correlated well with DAF-16/FOXO binding
sites previously identified in wild-type animals4 (Fig. S3a). And DAF-16/FOXO as well as
SWI/SNF binding sites were mostly located within promoter regions, consistent with these
proteins functioning in transcriptional regulation (Fig. 4a). Genes immediately downstream
of DAF-16/FOXO binding sites were strongly enriched for DAF-16/FOXO-activated genes,
while they were depleted for DAF-16/FOXO-repressed genes (Fig. 4b). 87% of the directly
regulated genes experienced activation and only 13% repression by DAF-16/FOXO,
suggesting that DAF-16/FOXO is predominantly a transcriptional activator.
Given that DAF-16/FOXO and SWI/SNF form a complex (Fig. 1d,e, Table S1), we tested if
they would colocalize also on chromatin. Indeed, SWSN-4/BRG1 and SWSN-1/
BAF155/170 were strongly enriched right at the summits of DAF-16/FOXO binding sites
(Fig. 4c,e), supporting the model of DAF-16/FOXO-SWI/SNF interaction. And the fact that
this colocalization occurred not only at some but the majority DAF-16/FOXO binding sites
(Fig. 4d,e), further supports the intimate connection between DAF-16/FOXO and this
cofactor.
DAF-16/FOXO recruits SWI/SNF to directly activated target genes
There is substantial precedence for transcription factors to employ chromatin remodellers as
cofactors12. In the case of SWI/SNF, some transcription factors recruit it to target promoters
to induce local nucleosome repositioning which alters the accessibility of cis-regulatory
promoter elements to regulate transcription22. In order to test if DAF-16/FOXO employs
SWI/SNF in a similar manner, we investigated whether their binding to DAF-16/FOXO
target promoters depends on each other. Inactivation of SWI/SNF by use of swsn-1(os22ts)
at restrictive temperature had no effect on DAF-16/FOXO expression, nuclear localization,
nor its binding to target promoters (Fig. 5a, S3b,c). Next we looked at the SWI/SNF
catalytic core subunit, SWSN-4/BRG1. Again, loss of DAF-16/FOXO did not alter
SWSN-4/BRG1 expression levels (Fig. S3b), its nuclear localization (Fig. S3c), nor did we
observe significant changes in the abundance of SWSN-4/BRG1 at promoters that were
either non-regulated or repressed by DAF-16/FOXO (Fig. 5b). However, specifically at a
large fraction of promoters that were directly bound and activated by DAF-16/FOXO (e.g.
promoters of sod-3, ctl-3, or hil-1) we observed a substantial loss of SWSN-4/BRG1 binding
in the absence of DAF-16/FOXO (Fig. 5b,d, S4a). As an additional control, we investigated
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promoters that were activated by DAF-16/FOXO (as judged by mRNA-Seq) but were
lacking a DAF-16/FOXO binding site, assuming that these are only indirect targets of
DAF-16/FOXO, e.g. regulated by transcription factors or other events downstream of
DAF-16/FOXO. Here we observed no change in SWSN-4/BRG1 binding upon loss of
DAF-16/FOXO, suggesting that SWSN-4/BRG1 recruitment at directly DAF-16/FOXO-
activated promoters is indeed controlled by the physical presence of DAF-16/FOXO and not
mere events of transcriptional activation (Fig. 5b). Findings for SWSN-4/BRG1 were
confirmed by analysis of SWSN-1/BAF155/170, yielding similar results (Fig. 5c, S3b, S4a,
data not shown). Results were additionally confirmed and replicated by conventional ChIP-
qPCR experiments (Fig. S4b). We conclude that DAF-16/FOXO can employ SWI/SNF as a
cofactor in the manner previously described for other transcription factors, and hence we
infer the following model for how DAF-16/FOXO may activate its target genes: DAF-16/
FOXO binds promoters independent of SWI/SNF, presumably by directly accessing its
target sequences, and at promoters that DAF-16/FOXO directly activates, it aids the
recruitment of SWI/SNF, thereby inducing local chromatin remodelling. This remodelling
enhances accessibility of activatory cis-regulatory promoter elements for binding by
downstream components (e.g. the transcription machinery), thereby resulting in
transcriptional activation (Fig. S5).
SWI/SNF is required for DAF-16/FOXO-mediated dauer formation
Given our collective evidence that DAF-16/FOXO employs SWI/SNF as a gene-activation-
specific cofactor, we then wondered about the importance of this cofactor for the various
DAF-16/FOXO-mediated functions in the animal. In C. elegans, DAF-16/FOXO is required
for entry into the dauer state, a developmental arrest or diapause state that allows for
survival in many adverse conditions23. We induced this state by inactivating insulin-like
signalling and tested whether RNAi against SWI/SNF subunits was able to suppress it.
Consistent with SWI/SNF being an important cofactor to DAF-16/FOXO, not only loss of
daf-16 but also of several SWI/SNF subunits prevented the formation of SDS-resistant dauer
larvae (Fig. 6a). Upon closer investigation, we found that in absence of SWI/SNF animals
attempted dauer entry, but full execution of the dauer program failed, leading instead to a
DAF-16/FOXO-dependent developmental arrest around the L3 stage (Fig. S6a). These
arrested animals lacked the typical longevity of dauer larvae and frequently were void of
dauer-specific anatomical features such as the hypodermal alae or the pharyngeal plug (Fig.
S6b–d). Consistent with our gene expression data (Fig. 2b,d), defective dauer formation was
specifically observed upon loss of either the core SWI/SNF subunits SWSN-4/BRG1 and
SWSN-1/BAF155/170 or the BAF signature subunit SWSN-8/OSA, while loss of PBAF
signature subunits PBRM-1/Polybromo, TAG-298/BRD7, or SWSN-7/BAF200 did not
disrupt dauer formation. This once again implies a specific role for a BAF-like subclass of
SWI/SNF in mediating DAF-16/FOXO functions.
Given this loss-of-function phenotype for SWI/SNF, we also tested whether overexpression
of the SWI/SNF subunits SWSN-4/BRG1 or SWSN-1/BAF155/170 could promote dauer
formation. Although gain-of-function phenotypes from such approach may be difficult to
obtain or interpret due to the multi-subunit nature of the SWI/SNF complex and its
requirement to be targeted to the appropriate sites, we observed a daf-16-dependent
moderate enhancement of dauer formation in daf-2(e1370ts) animals at 22°C (Fig. S6e).
SWI/SNF is required for DAF-16/FOXO-mediated longevity and stress resistance
Beyond its role in dauer formation, DAF-16/FOXO is a potent mediator of lifespan
extension, in particular during decreased insulin-like signalling. Inactivation of the SWI/
SNF core subunits SWSN-4/BRG1 or SWSN-1/BAF155/170 by RNAi fully suppressed this
lifespan extension (Fig. 6b,d). Partial suppression was seen upon RNAi against the non-core
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subunit SWSN-3/BAF57 (Fig. S7a). Even post-developmental RNAi against SWI/SNF
subunits was sufficient to partially suppress DAF-16/FOXO-induced lifespan extension
(Fig. 6e, Fig. S7b). All lifespan phenotypes induced by SWI/SNF RNAi were diminished in
daf-16(0) mutant worms, consistent with SWI/SNF functioning as a cofactor to and thus in
the same pathway as DAF-16/FOXO (Fig. 6c,e, Fig. S7b). We further confirmed these
phenotypes by mutant analysis. Consistent with the RNAi results, the hypomorphic alleles
swsn-4(os13ts) and swsn-1(os22ts) each impaired DAF-16/FOXO-mediated lifespan
extension (Fig. S7c,d). Unlike other SWI/SNF alleles or RNAi conditions tested, the
particularly strong allele swsn-1(os22ts) shortened the lifespan of daf-16(0) animals,
showing that SWI/SNF has some lifespan effects that are independent of DAF-16/FOXO.
But consistent with a requirement of SWI/SNF for DAF-16/FOXO function and thus the two
acting in the same pathway, daf-16(0) failed to shorten the lifespan of swsn-1(os22ts)
animals (Fig. S7d).
The lifespan extending capabilities of DAF-16/FOXO are highly correlated with its ability
to induce stress response pathways3,24. We tested if SWI/SNF is required for the DAF-16/
FOXO-mediated stress resistance of insulin-like signalling mutants. Inactivation of SWI/
SNF by swsn-1(os22ts) or swsn-3(RNAi) specifically blocked the enhanced resistance of
daf-2 mutants to oxidative stress (tBuOOH, Fig. 6f, S7e). In addition, swsn-1(os22ts) was
able to block enhanced resistance of daf-2 mutants to heat stress (32°C, Fig. S7f).
Inactivation of SWI/SNF showed a much lesser effect in daf-16 mutant backgrounds (Fig.
6f, S7e,f), again suggesting that SWI/SNF functions in the same pathway as DAF-16/
FOXO. Thus consistent with SWI/SNF being an important cofactor to DAF-16/FOXO, it is
not only required for DAF-16/FOXO-mediated gene regulation, but it actually is required
for a broad range of DAF-16/FOXO-mediated functions in the animal, in particular dauer
formation, stress resistance, and the promotion of longevity.
Discussion
Despite our extensive knowledge of pathways leading to DAF-16/FOXO activation, it long
remained elusive by which means and the help of which cofactors activated DAF-16/FOXO
regulates transcription and thus confers its suite of beneficial effects upon the organism. Our
study provided the first systematic identification of DAF-16/FOXO cofactors, which in itself
provides a significant resource for future studies, and by focusing on its most prominent
candidate, the chromatin remodeller SWI/SNF, we were able to illuminate the transcription-
regulatory events downstream of DAF-16/FOXO activation. We showed that DAF-16/
FOXO is predominantly a transcriptional activator and provided mechanistic insight into
how this activation may be achieved – namely by DAF-16/FOXO recruiting a BAF-like
subclass of SWI/SNF to target promoters. Extensive exploration of SWI/SNF function in
other systems suggests that this recruitment induces local chromatin remodelling to enable
binding of downstream transcriptional components and thereby activates transcription22.
These findings also jibe with previous implications of DAF-16/FOXO as a pioneer
transcription factor25,26, suggesting that specifically upon pro-longevity stimuli DAF-16/
FOXO is activated and autonomously binds to a wide range of target promoters where it
nucleates their transcriptional activation by alteration of chromatin states.
Chromatin states and their alteration were previously shown to have profound stress
responsive and lifespan-regulatory effects, but those described alterations were mostly
limited to epigenetic changes (i.e. histone methylation27,28 or acetylation29) and their
mechanistic link to known stress responsive and lifespan-regulatory pathways often
remained unclear. We now established DAF-16/FOXO-controlled stress-responsive and
lifespan-regulatory roles for a type of chromatin alteration fundamentally distinct from
epigenetic changes, namely ATP-dependent chromatin remodelling at the hands of SWI/
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SNF. This opens a new dimension to how an alteration of chromatin states can regulate
stress response and longevity. Also any potential cross-talk between this ATP-dependent
chromatin remodelling and lifespan-regulatory epigenetic marks will be important to
investigate in the future. For example, enrichment of SWI/SNF at DAF-16/FOXO binding
sites is substantially but not entirely dependent on DAF-16/FOXO (Fig. 5b–d, Fig. S4) and
thus may be supported by other factors or epigenetic marks, with histone acetylation being a
strong candidate30.
Finally, we would like to note that FOXO and SWI/SNF are both evolutionarily conserved
and that FOXO also has lifespan regulatory roles in humans31,32. Hence the here described
roles of SWI/SNF may be conserved, and their further exploration may eventually benefit
our understanding of aging and age-related diseases in humans.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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DAF-16/FOXO binds to the chromatin remodeller SWI/SNF. (a) C. elegans strains yielding
inactive cytoplasmic DAF-16/FOXO (daf-18(mg198lf)/PTEN) or active nuclear DAF-16/
FOXO (daf-2(e1370ts)/insulin-IGF receptor) were shifted for 20 h to restrictive temperature,
lysed and lysates separated on a Superose 6 size-exclusion column. Fractions were analysed
by SDS-PAGE and western blotting. (b) Schematics of the screen for DAF-16/FOXO
cofactors. (c) SDS-PAGE/silver stain analysis of large-scale α-GFP immunoprecipitations
from indicated strains. (d,e) Confirmatory co-IPs. DAF-16/FOXO::FLAG (d) or SWSN-4/
BRG1::GFP (e) were immunoprecipitated from whole-worm lysates of the indicated strains.
50 U/ml Benzonase was added to eliminate DNA- or RNA-mediated interactions. Samples
were analysed by SDS-PAGE and western blotting. For some inputs only fractions were
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loaded: 2% for SWSN-1::GFP (d), 2% for DAF-16::FLAG (e), and 20% for SWSN-4::GFP
(e).
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A BAF-like subclass of SWI/SNF is required for regulation of DAF-16/FOXO target genes.
Psod-3::GFP; daf-2(e1370ts) or Pins-7::ins-7::GFP animals were grown from the L1-stage
on indicated RNAi bacteria. daf-2(e1370ts) was inactivated by shift to restrictive
temperature at the L4-stage. GFP-fluorescence was evaluated on day 4 of adulthood (n=50
animals). Representative images are shown (scale bar: 100 μm) (a,c). Common SWI/SNF
subunits or ones specific to the subclasses BAF or PBAF are indicated accordingly (b,d).
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SWI/SNF is required for regulation of a large fraction of DAF-16/FOXO target genes – in
particular those activated by DAF-16/FOXO. Wild-type, daf-2(e1370ts), daf-2(e1370ts);
daf-16(0), and daf-2(e1370ts); swsn-1(os22ts) C. elegans were grown to the L4-stage, then
shifted to restrictive temperature. After 20 h, genome-wide mRNA expression levels were
determined by mRNA-Seq. (a) Scatter-plots comparing gene expression in wild-type to that
of various mutant strains. Only genes either significantly induced by daf-2(e1370ts) (left
panel) or repressed by daf-2(e1370ts) (right panel) are shown. Colours indicate the strains in
which the gene expression was analysed. As indicated by reversion of many genes to wild-
type expression levels (shift of genes to the plots’ indicated diagonals), daf-16(0)
extensively and swsn-1(os22ts) partially suppress the gene expression changes of
daf-2(e1370ts) animals. (b) Confirmation of the mRNA-Seq data by quantitative RT-PCR,
looking at the expression levels of endogenous sod-3, mtl-1, hsp-12.6, and ins-7. Expression
levels shown are relative to wild-type levels (black dotted lines). Consistent with the
mRNA-Seq results, daf-16(0) tends to fully and mutants in SWI/SNF tend to partially
suppress the differential gene expression caused by daf-2(e1370ts). (c) Significant overlap
between genes regulated by DAF-16/FOXO and SWSN-1/BAF155/170 (hypergeometric
test). Genes downregulated in either daf-2(e1370ts); daf-16(0) or daf-2(e1370ts);
swsn-1(os22ts) compared to daf-2(e1370ts) are shown in the upper diagram, genes
upregulated in these comparisons are shown in the lower diagram. (d) Correlation between
the extent of DAF-16/FOXO- and SWI/SNF-mediated differential gene expression in
daf-2(e1370ts) animals. Red lines represent trendlines, blue numbers show the fraction of
genes that are either up- or downregulated in swsn-1(os22ts), n denotes the number of
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DAF-16/FOXO-non-regulated, repressed, or activated genes contributing to each of the
plots. Specifically for genes activated by DAF-16/FOXO in daf-2(e1370ts), the extent of
DAF-16/FOXO-mediated activation correlates with an increasing dependence on SWI/SNF,
as indicated by the declining trendline in the plot on the right.
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SWI/SNF extensively associates with DAF-16/FOXO-bound promoter regions. C. elegans
of either daf-2(e1370ts); DAF-16::GFP, daf-2(e1370ts); SWSN-4::GFP, or daf-2(e1370ts);
SWSN-1::GFP were grown asynchronously and e1370ts was inactivated by a 20h shift to
restrictive temperature. ChIP-Seq of GFP-tagged proteins was performed and binding sites
were determined. (a) Each binding site was associated with its closest transcriptional start
site (TSS) and distances were plotted, revealing that DAF-16/FOXO and SWI/SNF are
predominantly located within 2.5 kb of a TSS and thus within promoter regions. (b) Genes
in vicinity to a DAF-16/FOXO binding site are strongly enriched for DAF-16/FOXO-
activated and rather depleted for DAF-16/FOXO-repressed genes. This effect decays with
the distance of the binding site from the TSS. (c) DAF-16/FOXO bound promoter regions
are strongly enriched for binding by SWSN-4::GFP and SWSN-1::GFP. Mean read
distributions across all DAF-16/FOXO binding sites are shown for the indicated strains. (d)
Venn diagram showing the overlap between binding sites of DAF-16/FOXO, SWSN-4/
BRG1, and SWSN-1/BAF155/170. (e) Heat-map representation of the data contributing to
(c,d), further supporting that SWI/SNF binding occurs at the majority of DAF-16/FOXO
binding sites. Lines of the heat-map represent the individual DAF-16/FOXO-bound regions
and are sorted by intensity of DAF-16/FOXO binding.
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DAF-16/FOXO recruits SWI/SNF specifically to target promoters that are directly activated
by DAF-16/FOXO. C. elegans of either daf-2(e1370ts); DAF-16::GFP, daf-2(e1370ts);
swsn-1(os22ts); DAF-16::GFP, daf-2(e1370ts); SWSN-4::GFP, daf-2(e1370ts); daf-16(0);
SWSN-4::GFP, daf-2(e1370ts); SWSN-1::GFP, or daf-2(e1370ts); daf-16(0);
SWSN-1::GFP were grown asynchronously and e1370ts and os22ts alleles were inactivated
by a 20h shift to restrictive temperature. ChIP-Seq of GFP-tagged proteins was performed.
(a) DAF-16/FOXO binding to promoter regions is not affected by absence of SWI/SNF.
Mean read distributions across different subsets of DAF-16/FOXO target promoters are
shown for the indicated strains. n denotes the number of promoter regions used in each
analysis and p-values denote the significance of the change in DAF-16/FOXO binding.
Corresponding histograms illustrate that hardly any of the promoters underwent a binding
change larger than 2-fold. (b) Loss of DAF-16/FOXO impairs binding of SWSN-4/BRG1
specifically to promoters directly bound and activated by DAF-16/FOXO. Mean read
distributions across different subsets of DAF-16/FOXO target promoters are shown for the
indicated strains. n denotes the number of promoter regions used in each analysis and p-
values denote the significance of the change in SWSN-4/BRG1 binding. Corresponding
histograms illustrate the fraction of promoters that underwent a larger than 2-fold change in
SWSN-4 binding (colored regions). (c) Histograms illustrating that loss of DAF-16/FOXO
likewise impairs binding of SWSN-1/BAF155/170 specifically to promoters directly bound
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and activated by DAF-16/FOXO. (d) Prominent example of daf-16(0)-dependent changes in
SWSN-4/BRG1 binding to the sod-3 promoter (a promoter directly bound and activated by
DAF-16/FOXO). ChIP-Seq data was normalized, smoothed over 50 bp bins, and then
displayed in the UCSC genome browser.
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SWI/SNF is required for DAF-16/FOXO-mediated dauer formation, stress resistance, and
longevity. (a) Dauer suppression assay. Eggs of C. elegans with activated DAF-16/FOXO
(daf-2(e1370ts)) were placed on the indicated RNAi bacteria and grown at restrictive
temperature. Dauers were identified after 5 days based on morphology and their resistance
to 1 % SDS. Common SWI/SNF subunits or ones specific to the subclasses BAF or PBAF
are indicated accordingly. Marked RNAi clones (*,#) were significantly different from
control RNAi (t-Test; p<0.05), some of which (#) led to non-dauer arrest around the L3
stage. (see Fig. S6a) (n=50 animals; error bars are based on S.D. from 3 independent
experiments) (b–d) Lifespan phenotypes caused by inactivation of SWI/SNF. Indicated
strains were grown from the L1-stage on indicated RNAi bacteria. Animals were shifted to
restrictive temperature at the L4-stage. (e) Also post-developmental inactivation of SWI/
SNF impairs DAF-16/FOXO-mediated longevity. Indicated C. elegans strains were grown
from the L1-stage on E. coli HT115. At the L4-stage, animals were shifted to the indicated
RNAi bacteria and e1370ts was inactivated by shift to restrictive temperature. (f) Oxidative
stress resistance assay. Indicated strains were grown to the L4-stage, when e1370ts and
os22ts alleles were inactivated by shift to restrictive temperature. 24 h later, animals were
exposed to 6 mM tert-Butylhydroperoxide (tBuOOH) and their survival was monitored. All
survival data of panels (b–f) was obtained from a minimum of 100 animals per condition,
mean survival times and S.E.M. were obtained by Kaplan-Meier analysis, and significant
differences between conditions were determined by log-rank test (for exact numbers of
animals and statistical data see Table S9).
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Table 1
Short-list of candidate DAF-16/FOXO cofactors required for DAF-16/FOXO function. Table was sorted by
the intensity of the lifespan phenotypes. For the full list of functional evaluation data see Tables S2–S6.
*
For rpn-9, baf-1 and cct-8 several RNAi clones were tested and the results were averaged for this table.
#
For a description of the GFP expression scoring scale see table S3.
§
Intensity of the red color denotes the intensitiy of the phenotype.
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